Pursuant to Regulation 30 of SEBI(LODR) Regulations 2015, we wish to inform you that the Board of Directors of the Company at their meeting held on 11.05.2026, has inter alia considered ....
KOVAI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors has approved the transfer of the Company's Allied Health Sciences (AHS) Courses division to Dr NGP Research and Educational Trust via a slump sale for cash consideration of Rs. 84.54 lakhs. The AHS division contributed Rs. 396.37 lakhs in turnover (0.29% of total) but had a negative net worth of Rs. -339.13 lakhs for FY 2025. The sale is driven by new regulatory requirements under the National Commission for Allied and Healthcare Professions Act, 2021 that require additional infrastructure investment. The company intends to focus on core medical education programmes with higher returns. The Business Transfer Agreement is expected to be executed before May 31, 2026, with completion by November 30, 2026. This is a related party transaction as promoter group directors are trustees of the buying trust, but it is conducted at arm's length with independent valuation support.
Minimal financial impact as the AHS division contributed less than 1% of revenue and had negative net worth. The Rs. 84.54 lakh cash inflow is small relative to the company's total turnover of Rs. 13,711 lakh. No change in shareholding pattern will occur.